Angiogen

Angiogen is a biopharmaceutical company dedicated to developing treatments for solid and vascular tumors in the United States. Its pipeline product, Angiostatic Cocktail, generates angiogenesis-inhibiting proteins. Angiogen LLC has established a strategic alliance with Genentech.